Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug ...

A primary challenge in finally achieving high value healthcare in the US is discovering how to harness the comprehensive and ...

Under budget legislation passed by the House on May 22, Medicaid enrollees would face work requirements two years sooner than ...

Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements ...

With more than a fifth of kidneys now allocated outside the established order, serious concerns about transparency, fairness, ...

Beneficiaries’ initial enrollment choices, whether active or passive, tend to have long-lasting implications because ...

Adjusted estimates of the cost implications of projected Medicare Advantage growth are lacking and essential to discussions ...

Policymakers, researchers, community leaders, and advocates must continue their efforts to improve maternal health, including ...

Rebuilding trust between women and the health care system is critical to address the root causes that have led us where we ...

Although burnout has dominated discussions of health care worker well-being, including moral injury—both as a way to describe ...

The US has pioneered advanced technologies in almost all economic sectors only to watch the subsequent commercialization, ...

Analysis For each drug’s indications, and to mirror the FDA’s call in the action plan that clinical trial enrollment should mirror prevalence, we compared the share of Black and White patients ...